Pancreatic Cancer Research

ResearcherSoochow UniversityActive in the last 2 years

Quansheng Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4712-0731; OpenAlex author ID A5016683563. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 5

  1. Oncogenic CD44 is required for pancreatic cancer cell tumorigenesis and CD44 gene knockout is a new strategy for targeted pancreatic cancer therapy Co-author DOI 10.21203/rs.3.rs-3677039/v1↗
  2. Lycorine inhibits pancreatic cancer cell growth and neovascularization by inducing Notch1 degradation and downregulating key vasculogenic genes. Co-author DOI 10.1016/j.bcp.2023.115833↗
  3. Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth. Last author DOI 10.1016/j.bcp.2019.05.010↗
  4. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes. Last author DOI 10.1016/j.ejphar.2017.11.019↗
  5. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer … Co-author DOI 10.1186/1471-2407-14-373↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peng Xu · 1 shared paper, 2024 · strength 0.21
  2. Jindan Qi · 1 shared paper, 2023 · strength 0.17
  3. Zhe Zhao · 1 shared paper, 2023 · strength 0.17
  4. Xingdong Xu · 2 shared papers, 2014–2019 · strength 0.13
  5. Hongyan Han · 1 shared paper, 2018 · strength 0.11
  6. Bin Zhang · 1 shared paper, 2019 · strength 0.09
  7. Ye Li · 1 shared paper, 2019 · strength 0.09
  8. Bo Yang · 1 shared paper, 2014 · strength 0.04
  9. Cong Cao · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.